73 related articles for article (PubMed ID: 38760460)
1. Myoglobin adsorption and saturation kinetics of the cytokine adsorber Cytosorb® in patients with severe rhabdomyolysis: a prospective trial.
Graf H; Gräfe C; Bruegel M; Zoller M; Maciuga N; Frank S; Weidhase L; Paal M; Scharf C
Ann Intensive Care; 2024 Jun; 14(1):96. PubMed ID: 38907120
[TBL] [Abstract][Full Text] [Related]
2. Corrigendum to < IN-VITRO APIXABAN REMOVAL BY CYTOSORB® WHOLE BLOOD ADSORBER. AN EXPERIMENTAL STUDY.> <[Journal of Cardiothoracic and Vascular Anesthesia 36/6 (2024) 1636 - 1644]>.
Røed-Undlien H; Schultz NH; Lunnan A; Husebråten IM; Wollmann BM; Molden E; Bjørnstad JL
J Cardiothorac Vasc Anesth; 2024 Jul; 38(7):1606-1607. PubMed ID: 38580477
[No Abstract] [Full Text] [Related]
3. Effect of CytoSorb on Interleukin-6.
Waalders NJB; Jansen A; Pickkers P
Crit Care Med; 2024 Mar; 52(3):e152-e153. PubMed ID: 38381019
[No Abstract] [Full Text] [Related]
4. Clarification on the Efficacy of Extracorporeal Purification Techniques in Critically Ill Patients with Liver Dysfunction.
Riva I; Faenza S
Blood Purif; 2024 May; ():1-4. PubMed ID: 38718774
[No Abstract] [Full Text] [Related]
5. Effect of CytoSorb on Interleukin-6: Erratum.
Crit Care Med; 2024 Jun; 52(6):e330. PubMed ID: 38752828
[No Abstract] [Full Text] [Related]
6. International registry on the use of the CytoSorb® adsorber in ICU patients : Study protocol and preliminary results.
Friesecke S; Träger K; Schittek GA; Molnar Z; Bach F; Kogelmann K; Bogdanski R; Weyland A; Nierhaus A; Nestler F; Olboeter D; Tomescu D; Jacob D; Haake H; Grigoryev E; Nitsch M; Baumann A; Quintel M; Schott M; Kielstein JT; Meier-Hellmann A; Born F; Schumacher U; Singer M; Kellum J; Brunkhorst FM
Med Klin Intensivmed Notfmed; 2019 Nov; 114(8):699-707. PubMed ID: 28871441
[TBL] [Abstract][Full Text] [Related]
7. Hemoperfusion with CytoSorb®: Current Knowledge on Patient Selection, Timing, and Dosing.
Klinkmann G; Koball S; Reuter DA; Mitzner S
Contrib Nephrol; 2023; 200():17-24. PubMed ID: 37263233
[TBL] [Abstract][Full Text] [Related]
8. Use of the CytoSorb adsorber in patients with acute-on-chronic liver failure.
Haselwanter P; Scheiner B; Balcar L; Semmler G; Riedl-Wewalka M; Schmid M; Reiberger T; Zauner C; Schneeweiss-Gleixner M
Sci Rep; 2024 May; 14(1):11309. PubMed ID: 38760460
[TBL] [Abstract][Full Text] [Related]
9. Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP)-a single center, open-label, three-arm, randomized, controlled intervention trial.
Sekandarzad A; Weber E; Prager EP; Graf E; Bettinger D; Wengenmayer T; Supady A
Trials; 2022 Mar; 23(1):222. PubMed ID: 35303938
[TBL] [Abstract][Full Text] [Related]
10. CytoResc - "CytoSorb" Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: A structured summary of a study protocol for a randomized controlled trial.
Stockmann H; Keller T; Büttner S; Jörres A; Kindgen-Milles D; Kunz JV; Leebmann J; Spies C; Träger K; Treskatsch S; Uhrig A; Willam C; Enghard P; Slowinski T;
Trials; 2020 Jun; 21(1):577. PubMed ID: 32586396
[TBL] [Abstract][Full Text] [Related]
11. The intensive care unit course and outcome in acute-on-chronic liver failure are comparable to other populations.
Meersseman P; Langouche L; du Plessis J; Korf H; Mekeirele M; Laleman W; Nevens F; Wilmer A; Van den Berghe G; van der Merwe SW
J Hepatol; 2018 Oct; 69(4):803-809. PubMed ID: 29730473
[TBL] [Abstract][Full Text] [Related]
12. Hemoperfusion with Cytosorb in pediatric patients with septic shock: A retrospective observational study.
Bottari G; Guzzo I; Marano M; Stoppa F; Ravà L; Di Nardo M; Cecchetti C
Int J Artif Organs; 2020 Sep; 43(9):587-593. PubMed ID: 32003289
[TBL] [Abstract][Full Text] [Related]
13. Blood Purification With CytoSorb in Critically Ill Patients: Single-Center Preliminary Experience.
Calabrò MG; Febres D; Recca G; Lembo R; Fominskiy E; Scandroglio AM; Zangrillo A; Pappalardo F
Artif Organs; 2019 Feb; 43(2):189-194. PubMed ID: 30156308
[TBL] [Abstract][Full Text] [Related]
14. Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failure.
Agarwal B; Cañizares RB; Saliba F; Ballester MP; Tomescu DR; Martin D; Stadlbauer V; Wright G; Sheikh M; Morgan C; Alzola C; Lavin P; Green D; Kumar R; Sacleux SC; Schilcher G; Koball S; Tudor A; Minten J; Domenech G; Aragones JJ; Oettl K; Paar M; Waterstradt K; Bode-Boger SM; Ibáñez-Samaniego L; Gander A; Ramos C; Chivu A; Stange J; Lamprecht G; Sanchez M; Mookerjee RP; Davenport A; Davies N; Pavesi M; Andreola F; Albillos A; Cordingley J; Schmidt H; Carbonell-Asins JA; Arroyo V; Fernandez J; Mitzner S; Jalan R
J Hepatol; 2023 Jul; 79(1):79-92. PubMed ID: 37268222
[TBL] [Abstract][Full Text] [Related]
15. Bridging patients with acute-on-chronic liver failure for transplantation: plasma exchange to stabilize multiorgan failure?
Stahl K; Bode C; David S
Intensive Care Med; 2023 Jul; 49(7):890-891. PubMed ID: 37178148
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
